GlassScriptPhysician profile
Heather N Lopez
NPI 1972953180
$2,292.70
in general payments reported to CMS, 2019-2025
23 companies · $454 in 2025
The $454 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.66 · 2020: $414 · 2021: $340 · 2022: $492 · 2023: $313 · 2024: $257 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,024.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $850.61 | 2020-2024 | |
| Medical Device Business Services, INC. | $325.00 | 2020 | |
| Mayne Pharma Commercial LLC | $231.87 | 2022-2025 | |
| Biogen, INC. | $168.82 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $93.76 | 2022-2025 | |
| Exeltis, USA INC. | $89.87 | 2023-2024 | Slynd |
| Exact Sciences Corporation | $81.83 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Agile Therapeutics, INC. | $65.65 | 2021-2023 | Twirla |
| Organon LLC | $60.67 | 2022-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $42.15 | 2021-2025 | Aptima |
| Shield Therapeutics INC | $38.79 | 2024-2025 | |
| Avion Pharmaceuticals | $38.03 | 2021-2022 | |
| Pfizer INC. | $27.75 | 2021 | |
| Ethicon US, LLC | $22.66 | 2019 | |
| Merck Sharp & Dohme LLC | $22.47 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $20.49 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $19.50 | 2025 | Exparel |
| Myovant Sciences INC. | $19.48 | 2022 | |
| Smith+Nephew, INC. | $17.32 | 2025 | "Acticoat 4"" X 4""", Pico 14 |
| Coopersurgical, INC. | $16.65 | 2025 | Paragard T 380a |
| Evofem Biosciences, INC. | $15.89 | 2021 | |
| Therapeuticsmd, INC. | $11.82 | 2021 | |
| Lupin INC. | $11.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.